Australia markets open in 8 hours 7 minutes

ProQR Therapeutics N.V. (PRQR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.90+0.16 (+2.39%)
As of 11:49AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close6.74
Open6.75
Bid6.90 x 800
Ask6.93 x 1000
Day's range6.73 - 6.92
52-week range3.40 - 9.46
Volume64,435
Avg. volume3,469,853
Market cap456.335M
Beta (5Y monthly)0.51
PE ratio (TTM)N/A
EPS (TTM)-1.03
Earnings date04 Aug 2021 - 09 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est25.44
  • ProQR to Present at Upcoming JMP Securities Life Sciences Conference
    GlobeNewswire

    ProQR to Present at Upcoming JMP Securities Life Sciences Conference

    LEIDEN, Netherlands & CAMBRIDGE, Mass., June 10, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that Company management will present during a fireside chat at the upcoming JMP Securities Life Sciences Conference. The presentation will be webcast live on June 17, 2021, from 3:00 – 3:25pm EDT. The live and archived webcast of the pre

  • What Kind Of Investors Own Most Of ProQR Therapeutics N.V. (NASDAQ:PRQR)?
    Simply Wall St.

    What Kind Of Investors Own Most Of ProQR Therapeutics N.V. (NASDAQ:PRQR)?

    Every investor in ProQR Therapeutics N.V. ( NASDAQ:PRQR ) should be aware of the most powerful shareholder groups...

  • ProQR (PRQR) Reports Q1 Loss, Misses Revenue Estimates
    Zacks

    ProQR (PRQR) Reports Q1 Loss, Misses Revenue Estimates

    ProQR (PRQR) delivered earnings and revenue surprises of -7.14% and -92.92%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?